FMS: Fresenius Medical Care AG - Summary | Jitta

Fresenius Medical Care AG

NYSE:FMS

Price
$19.69
Loss Chance
45.3%
3.92JITTA SCORE
36.01%Under Jitta Line
Jitta Ranking
58 / 1,127
696 / 4,938
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (37)
Financial Strength (61)
Return to Shareholders (30)
Competitive Advantage (39)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Dividend PayoutEvery year
Interest Coverage RatioGood
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2020-2023
Debt LevelHigh Long Term Debt
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.92
36.01%
2.06
244.26%
Health Care Services
6.23
30.59%
4.41
29.98%
6.03
21.79%
COMPANY DESCRIPTION
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.